CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	110	18	191	-	-	-
Market Cap Growth	-90.80%	-90.80%	-	-	-	-
Enterprise Value	109	17	439	-	-	-
Last Close Price	11.94	4.37	116.75	-	-	-
PS Ratio	0.46	0.47	6.60	-	-	-
PB Ratio	7.40	1.56	22.34	-	-	-
P/TBV Ratio	80.90	12.98	-	-	-	-
EV/Sales Ratio	2.91	0.46	15.14	-	-	-
Debt / Equity Ratio	2.35	2.35	3.28	-1.90	-4.23	-1.43
Asset Turnover	0.59	0.59	0.60	0.74	1.14	-
Inventory Turnover	26.62	26.62	19.13	17.26	23.16	-
Quick Ratio	0.74	0.74	0.84	0.24	0.22	0.23
Current Ratio	1.02	1.02	1.14	0.60	0.68	0.49
Return on Equity (ROE)	-219.68%	-219.68%	-	-	-	-
Return on Assets (ROA)	-9.45%	-9.45%	-25.30%	-20.69%	-39.83%	-
Return on Capital (ROIC)	-16.24%	-16.24%	-47.57%	-44.51%	-81.25%	-
Earnings Yield	-19.62%	-122.29%	-11.95%	-	-	-
FCF Yield	-14.33%	-88.25%	-6.61%	-	-	-
Buyback Yield / Dilution	-347.33%	-347.33%	-27.75%	-11.07%	-226.00%	-

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q